Stryker (SYK) is a publicly traded Healthcare sector company. As of November 17, 2026, SYK trades at $318.76 with a market cap of $118.29B and a P/E ratio of 28.72. SYK moved +2.19% today. Year to date, SYK is -8.98%; over the trailing twelve months it is -11.85%. Its 52-week range spans $267.00 to $404.87. Analyst consensus is strong buy with an average price target of $338.84. Rallies surfaces SYK's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for SYK shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $318.76 |
| Market Cap | $118.29B |
| P/E Ratio | 28.72 |
| EPS | $9.73 |
| Dividend Yield | 0.88% |
| 52-Week High | $404.87 |
| 52-Week Low | $267.00 |
| Volume | 3.63M |
| Avg Volume | 0 |
| Revenue (TTM) | $25.84B |
| Net Income | $3.73B |
| Gross Margin | 64.98% |
21 analysts cover SYK: 0 strong buy, 18 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $338.84.